Abigail Wilpers1,2,3,4, Anna Y Lynn5, Barbara Eichhorn3,6, Amy B Powne3,7, Megan Lagueux3,8, Janene Batten9, Mert Ozan Bahtiyar4, Cary P Gross1,10. 1. National Clinician Scholars Program, Yale School of Medicine and Yale School of Nursing, New Haven, Connecticut, USA. 2. Fetal Care Center, Yale New Haven Hospital, New Haven, Connecticut, USA. 3. Fetal Therapy Nurse Network, Chicago, Illinois, USA. 4. Department of Obstetrics, Gynecology, & Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA. 5. Department of Biomedical Engineering, Yale School of Medicine, New Haven, Connecticut, USA. 6. Fetal Diagnosis and Treatment Centers, UPMC Magee-Womens Hospital, Pittsburgh, Pennsylvania, USA. 7. UC Davis Fetal Care and Treatment Center, Sacramento, California, USA. 8. Neonatal Intensive Care Unit, Children's Hospital Colorado, Aurora, Colorado, USA. 9. Department of Research and Education Services, Yale University, New Haven, Connecticut, USA. 10. Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Abstract
BACKGROUND/ PURPOSE: Although maternal-fetal surgery to treat fetal anomalies such as spina bifida continues to grow more common, potential health disparities in the field remain relatively unexamined. To address this gap, we identified maternal-fetal surgery studies with the highest level of evidence and analyzed the reporting of participant sociodemographic characteristics and representation of racial and ethnic groups. METHODS: We conducted a systematic review of the scientific literature using biomedical databases. We selected randomized control trials (RCTs) and cohort studies with comparison groups published in English from 1990 to May 5, 2020. We included studies from across the globe that examined the efficacy of fetal surgery for twin-twin transfusion syndrome (TTTS), obstructive uropathy, congenital diaphragmatic hernia (CDH), myelomeningocele (MMC), thoracic lesions, cardiac malformations, or sacrococcygeal teratoma. We determined the frequency of reporting of age, gravidity/parity, race, ethnicity, education level, language spoken, insurance, income level, and relationship status. We identified whether sociodemographic factors were used as inclusion or exclusion criteria. We calculated the racial and ethnic group representation for studies in the USA using the participation-to-prevalence ratio (PPR). RESULTS: We included 112 studies (10 RCTs, 102 cohort) published from 1990-1999 (8%), 2000-2009 (30%), and 2010-2020 (62%). Most studies were conducted in the USA (47%) or Europe (38%). The median sample size was 58. TTTS was the most common disease group (37% of studies), followed by MMC (23%), and CDH (21%). The most frequently reported sociodemographic variables were maternal age (33%) and gravidity/parity (20%). Race and/or ethnicity was only reported in 12% of studies. Less than 10% of studies reported any other sociodemographic variables. Sociodemographic variables were used as exclusion criteria in 13% of studies. Among studies conducted in the USA, White persons were consistently overrepresented relative to their prevalence in the US disease populations (PPR 1.32-2.11), while Black or African-American, Hispanic or Latino, Asian, American-Indian or Alaska-Native, and Native-Hawaiian or other Pacific Islander persons were consistently underrepresented (PPR 0-0.60). CONCLUSIONS: Sociodemographic reporting quality in maternal-fetal surgery studies is poor and inhibits examination of potential health disparities. Participants enrolled in studies in the USA do not adequately represent the racial and ethnic diversity of the population across disease groups.
BACKGROUND/ PURPOSE: Although maternal-fetal surgery to treat fetal anomalies such as spina bifida continues to grow more common, potential health disparities in the field remain relatively unexamined. To address this gap, we identified maternal-fetal surgery studies with the highest level of evidence and analyzed the reporting of participant sociodemographic characteristics and representation of racial and ethnic groups. METHODS: We conducted a systematic review of the scientific literature using biomedical databases. We selected randomized control trials (RCTs) and cohort studies with comparison groups published in English from 1990 to May 5, 2020. We included studies from across the globe that examined the efficacy of fetal surgery for twin-twin transfusion syndrome (TTTS), obstructive uropathy, congenital diaphragmatic hernia (CDH), myelomeningocele (MMC), thoracic lesions, cardiac malformations, or sacrococcygeal teratoma. We determined the frequency of reporting of age, gravidity/parity, race, ethnicity, education level, language spoken, insurance, income level, and relationship status. We identified whether sociodemographic factors were used as inclusion or exclusion criteria. We calculated the racial and ethnic group representation for studies in the USA using the participation-to-prevalence ratio (PPR). RESULTS: We included 112 studies (10 RCTs, 102 cohort) published from 1990-1999 (8%), 2000-2009 (30%), and 2010-2020 (62%). Most studies were conducted in the USA (47%) or Europe (38%). The median sample size was 58. TTTS was the most common disease group (37% of studies), followed by MMC (23%), and CDH (21%). The most frequently reported sociodemographic variables were maternal age (33%) and gravidity/parity (20%). Race and/or ethnicity was only reported in 12% of studies. Less than 10% of studies reported any other sociodemographic variables. Sociodemographic variables were used as exclusion criteria in 13% of studies. Among studies conducted in the USA, White persons were consistently overrepresented relative to their prevalence in the US disease populations (PPR 1.32-2.11), while Black or African-American, Hispanic or Latino, Asian, American-Indian or Alaska-Native, and Native-Hawaiian or other Pacific Islander persons were consistently underrepresented (PPR 0-0.60). CONCLUSIONS: Sociodemographic reporting quality in maternal-fetal surgery studies is poor and inhibits examination of potential health disparities. Participants enrolled in studies in the USA do not adequately represent the racial and ethnic diversity of the population across disease groups.
Authors: Rubén A Quintero; Ramen H Chmait; Takeshi Murakoshi; Zofia Pankrac; Malgorzata Swiatkowska; Patricia W Bornick; Mary H Allen Journal: Am J Obstet Gynecol Date: 2006-04 Impact factor: 8.661
Authors: Mieke M Cannie; Jacques C Jani; Frederik De Keyzer; Karel Allegaert; Steven Dymarkowski; Jan Deprest Journal: Radiology Date: 2009-06-09 Impact factor: 11.105
Authors: Katika Nawapun; Mary Patrice Eastwood; Daysi Diaz-Cobos; Julio Jimenez; Michael Aertsen; Olga Gomez; Filip Claus; Eduard Gratacós; Jan Deprest Journal: Prenat Diagn Date: 2015-09-29 Impact factor: 3.050
Authors: Michael S Schechter; Tiebin Liu; Minn Soe; Mark Swanson; Elisabeth Ward; Judy Thibadeau Journal: Pediatrics Date: 2015-03-16 Impact factor: 7.124
Authors: Elisa Done; Anne Debeer; Leonardo Gucciardo; Tim Van Mieghem; Paul Lewi; Roland Devlieger; Luc De Catte; Liesbeth Lewi; Karel Allegaert; Jan Deprest Journal: Fetal Diagn Ther Date: 2014-11-08 Impact factor: 2.587
Authors: Stefanie Riddle; Robert Huddle; Foong-Yen Lim; Charles Stevenson; Kristin Dean; Karen Sparling; Matthew Fenchel; Kurt Schibler Journal: J Matern Fetal Neonatal Med Date: 2019-07-25